Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades

Arthritis Care and Research

Volumn 66, Issue 5, 2014, Pages 671-678

  Overman, Cécile L ^a   Jurgens, Maud S ^b   Bossema, Ercolie R ^a   Jacobs, Johannes W G ^b   Bijlsma, Johannes W J ^b   Geenen, Rinie ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DISEASE ACTIVITY; DISTRESS SYNDROME; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIPLE LINEAR REGRESSION ANALYSIS; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PSYCHOLOGICAL WELL BEING; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84899126780     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22211     Document Type: Article

References (50)

1. Dickens C, McGowan L, Clark-Carter D, Creed F,. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002; 64: 52-60. (Pubitemid 34137399)
2. VanDyke MM, Parker JC, Smarr KL, Hewett JE, Johnson GE, Slaughter JR, et al. Anxiety in rheumatoid arthritis. Arthritis Rheum 2004; 51: 408-12. (Pubitemid 38725140)
3. Isik A, Koca SS, Ozturk A, Mermi O,. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26: 872-78. (Pubitemid 46951281)
4. Overman CL, Bossema ER, van Middendorp H, Wijngaards-de Meij L, Verstappen SM, Bulder M, et al. The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Ann Rheum Dis 2012; 71: 192-7.
5. Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009; 68: 1666-72.
6. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS,. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002; 61: 290-7. (Pubitemid 34257737)
7. Van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996; 124: 699-707.
8. Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, ter Borg EJ, et al, on behalf of the Utrecht Arthritis Cohort Study Group. Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003; 48: 1797-807. (Pubitemid 36828673)
9. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007; 66: 1443-9. (Pubitemid 350032650)
10. Jurgens MS, Welsing PM, Jacobs JW,. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol 2012; 30: S56-63.
11. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18. (Pubitemid 27351112)
12. Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, et al. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med 2012; 156: 329-39.
13. Furst D, Breedveld F, Kalden J, Smolen JS, Burmester GR, Bijlsma JW, et al. Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis 2005; 64: iv2-14. (Pubitemid 41532009)
14. Smolen JS, Boers M, Abadie EC, Breedveld FC, Emery P, Bardin T, et al. Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Curr Med Res Opin 2011; 27: 315-25.
15. Jung YO, Kim HA,. Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis. Korean J Intern Med 2012; 27: 378-87.
16. Sharma P, Pathak K,. Are biological targets the final goal for rheumatoid arthritis therapy? Expert Opin Biol Ther 2012; 12: 1611-22.
17. Smith RD, Polley HF,. Rest therapy for rheumatoid arthritis. Mayo Clin Proc 1978; 53: 141-5. (Pubitemid 8292851)
18. De Ridder D, Geenen R, Kuijer R, van Middendorp H,. Psychological adjustment to chronic disease. Lancet 2008; 372: 246-55. (Pubitemid 351978113)
19. De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003; 48: 2415-24. (Pubitemid 37129418)
20. Geenen R, Mulligan K, Shipley M, Newman S,. Psychosocial dimensions of the rheumatic diseases. In:, Bijlsma JW, Burmeister GR, da Silva JA, Faarvang KL, Hachulla E, Mariette X, editors. EULAR compendium on rheumatic diseases. London: BMJ Publishing Group; 2009. p. 635-50.
21. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, et al. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ 2009; 181: 787-96.
22. Sokka T, Kautiainen H, Hakkinen A, Hannonen P,. Radiographic progression is getting milder in patients with early rheumatoid arthritis: results of 3 cohorts over 5 years. J Rheumatol 2004; 31: 1073-82. (Pubitemid 38715880)
23. Finckh A, Choi HK, Wolfe F,. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 2006; 65: 1192-7. (Pubitemid 44277395)
24. Pincus T, Sokka T, Kautiainen H,. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005; 52: 1009-19. (Pubitemid 40530106)
25. Heiberg T, Finset A, Uhlig T, Kvien TK,. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 191-5. (Pubitemid 40193610)
26. Soderlin MK, Lindroth Y, Jacobsson LT,. Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmö, Sweden. Rheumatology (Oxford) 2007; 46: 1355-8. (Pubitemid 47244513)
27. Uhlig T, Heiberg T, Mowinckel P, Kvien TK,. Rheumatoid arthritis is milder in the new millennium: health status in RA patients 1994-2004. Ann Rheum Dis 2008; 67: 1710-5.
28. Soderlin MK, Lindroth Y, Turesson C, Jacobsson LT,. A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmö, Sweden, 1997-2005. Scand J Rheumatol 2010; 39: 206-11.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
30. Huiskes CJ, Kraaimaat FW, Bijlsma JW,. Measuring health status in rheumatoid arthritis: development and refinement of a Dutch health status instrument. Gedrag Gezond 1990; 18: 78-89. In Dutch.
31. Huiskes CJ, Kraaimaat FW, Bijlsma JW,. IRGL: Impact of Arthritis on Health and Lifestyle self-report questionnaire. Nijmegen: University Medical Center St. Radboud Nijmegen; 2004. In Dutch.
32. Zwart F, Spooren J,. Development of a self-report questionnaire for depression. Utrecht: University Medical Center Utrecht; 1982. In Dutch.
33. Spielberger CD, Gorsuch RL, Lushene RE,. Manual of the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologists Press; 1970.
34. Van der Ploeg HM, Defares PB, Spielberger CD,. Handleiding bij de ZelfBeoordelingsVragenlijst ZBV. Lisse: Swets & Zeitlinger; 1980.
35. Fries JF, Spitz PW, Young DY,. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982; 9: 789-93.
36. Bijlsma JW, Oude Heuvel CH, Zaalberg A,. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990; 3: 71-4. (Pubitemid 20307173)
37. Krishnan E, Fries JF,. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003; 115: 371-6. (Pubitemid 37311254)
38. Krishnan E, Sokka T, Hakkinen A, Hubert H, Hannonen P,. Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum 2004; 50: 953-60. (Pubitemid 38326196)
39. Van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994; 21: 425-9. (Pubitemid 24102824)
40. Thompson PW, Silman AJ, Kirwan JR, Currey HL,. Articular indices of joint inflammation in rheumatoid arthritis: correlation with the acute-phase response. Arthritis Rheum 1987; 30: 618-23. (Pubitemid 17104900)
41. Preacher KJ, Hayes AF,. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879-91.
42. Evers AW, Zautra A, Thieme K,. Stress and resilience in rheumatic diseases: a review and glimpse into the future. Nat Rev Rheumatol 2011; 7: 409-15.
43. Dantzer R,. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001; 933: 222-34. (Pubitemid 32386037)
44. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002; 26: 643-52. (Pubitemid 34260983)
45. Beets G, van Nimwegen N,. Population issues in The Netherlands. Rev Popul Soc Policy 2000; 9: 87-117.
46. OECD iLibrary. Education at a glance 2012: highlights. 2012. URL: http://dx.doi.org/10.1787/eag-highlights-2012-en.
47. Veenhoven R,. Is life getting better? Eur Psychol 2005; 10: 330-43.
48. Twenge JM,. The age of anxiety? The birth cohort change in anxiety and neuroticism, 1952-1993. J Pers Soc Psychol 2000; 79: 1007-21.
49. Welsing PM, Fransen J, van Riel PL,. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005; 52: 2616-24. (Pubitemid 41369089)
50. Boonen A, Landewe R,. Health status in rheumatoid arthritis over 7 years. Ann Rheum Dis 2005; 64: 173-5. (Pubitemid 40193605)